UDG Healthcare (LON:UDG) had its target price lowered by Jefferies Group from GBX 855 ($11.51) to GBX 800 ($10.77) in a research report released on Monday, Marketbeat reports. The firm currently has a hold rating on the stock.

A number of other research firms also recently commented on UDG. Peel Hunt increased their price objective on shares of UDG Healthcare from GBX 840 ($11.31) to GBX 860 ($11.57) and gave the company an add rating in a research note on Tuesday, October 31st. Numis Securities downgraded shares of UDG Healthcare to a reduce rating and set a GBX 765 ($10.30) price objective on the stock. in a research note on Thursday, November 9th. N+1 Singer increased their price objective on shares of UDG Healthcare from GBX 770 ($10.36) to GBX 841 ($11.32) and gave the company a hold rating in a research note on Wednesday, November 1st. Liberum Capital reiterated a hold rating and set a GBX 884 ($11.90) price objective on shares of UDG Healthcare in a research note on Wednesday, November 15th. Finally, Stifel Nicolaus reiterated a hold rating and set a GBX 815 ($10.97) price objective on shares of UDG Healthcare in a research note on Thursday, November 30th. One analyst has rated the stock with a sell rating and six have given a hold rating to the company’s stock. UDG Healthcare currently has an average rating of Hold and a consensus price target of GBX 826.43 ($11.12).

UDG Healthcare (LON:UDG) opened at GBX 855.50 ($11.51) on Monday. UDG Healthcare has a 52 week low of GBX 632.50 ($8.51) and a 52 week high of GBX 963 ($12.96).

The firm also recently announced a dividend, which will be paid on Monday, February 5th. Shareholders of record on Thursday, January 11th will be issued a dividend of $0.10 per share. This represents a dividend yield of 0.84%. This is a boost from UDG Healthcare’s previous dividend of $0.04. The ex-dividend date of this dividend is Thursday, January 11th.

TRADEMARK VIOLATION NOTICE: “UDG Healthcare (UDG) PT Lowered to GBX 800 at Jefferies Group” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/12/07/udg-healthcare-udg-pt-lowered-to-gbx-800-at-jefferies-group.html.

UDG Healthcare Company Profile

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for UDG Healthcare (LON:UDG)

Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.